MELISSA CARVER: Open Payments
NPI 1699755819 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,364 in 187 payments from 35 companies in 2025. Trend: 2023 $24,574 · 2024 $18,579 · 2025 $18,364
Speaker / faculty: $9,600Food & beverage: $4,195Travel & lodging: $3,071Long term medical supply or device loan: $1,147Consulting: $350
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 37 | $12,976 |
| Novartis Pharmaceuticals Corporation | 28 | $1,410 |
| Genentech USA, Inc. | 5 | $519 |
| Astellas Pharma US Inc | 7 | $513 |
| AstraZeneca Pharmaceuticals LP | 11 | $427 |
| Daiichi Sankyo Inc. | 5 | $254 |
| E.R. Squibb & Sons, L.L.C. | 14 | $247 |
| PFIZER INC. | 12 | $238 |
| GlaxoSmithKline, LLC. | 8 | $188 |
| Janssen Biotech, Inc. | 6 | $172 |
Products named: Trodelvy, KISQALI, Padcev, DATROWAY, OPDIVO, Tecentriq, IMBRUVICA, Lenvima.
Industry payments across FL — which companies pay providers there.
